Showing 1 - 5 results of 5 for search 'Insa Winzenborg', query time: 0.02s Refine Results
  1. 1
    Risankizumab: Mechanism of action, clinical and translational science

    Risankizumab: Mechanism of action, clinical and translational science by Yinuo Pang, Ronilda D'Cunha, Insa Winzenborg, Geertruida Veldman, Valerie Pivorunas, Kori Wallace

    Published 2024-01-01
    Get full text
    Article
  2. 2
    Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis‐Associated Pain: An Application of Markov Model

    Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis‐Associated Pain: An Application of Markov Model by Insa Winzenborg, Akshanth R. Polepally, Ahmed Nader, Nael M. Mostafa, Peter Noertersheuser, Juki Ng

    Published 2020-08-01
    Get full text
    Article
  3. 3
    Integrating real‐world data and modeling to project changes in femoral neck bone mineral density and fracture risk in premenopausal women

    Integrating real‐world data and modeling to project changes in femoral neck bone mineral density and fracture risk in premenopausal women by Denise Beck, Insa Winzenborg, Wei Gao, Nael M. Mostafa, Peter Noertersheuser, Stephanie E. Chiuve, Charlotte Owens, Mohamad Shebley

    Published 2021-07-01
    Get full text
    Article
  4. 4
    Exposure‐Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis‐Associated Pain

    Exposure‐Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis‐Associated Pain by Ahmed Abbas Suleiman, Ahmed Nader, Insa Winzenborg, Denise Beck, Akshanth R. Polepally, Juki Ng, Peter Noertersheuser, Nael M. Mostafa

    Published 2020-11-01
    Get full text
    Article
  5. 5
    Validation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis

    Validation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis by Sven Stodtmann, Ahmed Nader, Akshanth R. Polepally, Ahmed A. Suleiman, Insa Winzenborg, Peter Noertersheuser, Juki Ng, Nael M. Mostafa, Mohamad Shebley

    Published 2021-07-01
    Get full text
    Article

Search Tools: